Changes in clinical trials mandated by the advent of meta-analysis

Statistics in Medicine

Volumn 15, Issue 12, 1996, Pages 1263-1268

  Chalmers, Thomas C ^a   Lau, Joseph ^a  

^a TUFTS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOSTATISTICS; CLINICAL TRIAL; CONFERENCE PAPER; DECISION MAKING; META ANALYSIS; PREECLAMPSIA;

CALCIUM; CLINICAL TRIALS; DECISION MAKING; FEMALE; HUMANS; META-ANALYSIS; PLANNING TECHNIQUES; PRE-ECLAMPSIA; PREGNANCY; RESEARCH DESIGN; SELECTION BIAS; TREATMENT OUTCOME;

EID: 0030002305     PISSN: 02776715     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0258(19960630)15:12<1263::AID-SIM305>3.0.CO;2-K     Document Type: Conference Paper

References (22)

1. Lau, J., Schmid, C. H. and Chalmers, T. C. 'Cumulative meta-analysis of clinical trials builds evidence for exemplary medical care', Journal of Clinical Epidemiology, 48, 45-57 (1995).
2. Baum, M. L., Anish, D. S., Chalmers, T. C., Sacks, H. S., Smith, H. Jr. and Fagerstrom, R. M. 'A survey of clinical trials of antibiotic prophylaxis in colon surgery: evidence against further use of no-treatment controls', New England Journal of Medicine, 305, 795-799 (1981).
3. Freiman, J. A., Chalmers, T. C., Smith, H. Jr. and Kuebeler, R. R. 'The importance of beta, the type II error, and sample size in the design and interpretation of the randomized controlled trial: survey of two sets of "negative" trials', in Bailar, J. C. 3rd, and Mosteller, F. (eds), Medical Uses of Statistics, 2nd edn, NEJM Books, Boston, 1993, pp. 357-374.
4. Mittendorf, R., Aronson, M. P., Berry, R. E., Williams, M. A., Kupelnick, B., Klickstein, A., Herbst, A. L. and Chalmers, T. C. 'Avoiding serious infections associated with abdominal hysterectomy: a meta-analysis of antibiotic prophylaxis', American Journal of Obstetrics and Gynecology, 169, 1119-1124 (1993).
5. Enkin, M., Enkin, E., Chalmers, I. and Hemminki, E. 'Prophylactic antibiotics in association with caesarean section', in Chalmers, I., Enkin, M., Keirse, M. J. N. C. (eds), Effective care in Pregnancy and Childbirth, Oxford University Press, Oxford, England, 1989, pp. 1246-1270.
6. Sacks, H. S., Chalmers, T. C., Blum, A. L., Berrier , J. and Pagano, D. 'Endoscopic hemostasis: an effective therapy for bleeding peptic ulcers', Journal of the American Medical Association, 262, 494-499 (1990).
7. Chalmers, T. C. and Lau, J. 'Meta-analytic stimulus for changes in clinical trials', Statistical Methods in Medical Research, 2, 161-172 (1993).
8. Rothman, K. J. and Michels, K. B. The continuing unethical use of placebo controls', New England Journal of Medicine, 331, 394-398 (1994).
9. Lau, J., Chalmers, T. C. and Mosteller, F. 'How many you need depends on what is already known. Estimating the size of future randomized control trials based on meta-analysis', Abstract presented at the annual meeting of the International Society for Clinical Biostatistics, Copenhagen, 1992.
10. Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico (GISSI). 'Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction', Lancet, 1, 397-402 (1986).
11. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. 'Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2', Lancet, 2, 349-360 (1988).
12. Held, P. H., Yusuf, S. and Furberg, C. D. 'Calcium channel blockers in acute myocardial infarction and unstable angina: an overview', British Medical Journal, 299, 1187-1192 (1989).
13. Yusuf, S., Held, P. and Furberg, C. 'Update of effects of calcium antagonists in myocardial infarction or angina in light of the second Danish Verapamil Infarction Trails (DAVIT-II) and other recent trials', American Journal of Cardiology, 67, 1295-1297 (1991).
14. Unidentified speaker in the discussion following the presentation of Chalmers, T. C. and Lau, J. 'Randomized control trials and meta-analyses in gastroenterology: major achievements and future potential', Annals of the New York Academy of Science, 703, 105 (1993).
15. Pocock, S. J. 'When to stop a clinical trial', British Medical Journal, 305, 235-240 (1992).
16. Hughes, M. D., Freedman, L. S. and Pocock, S. J. The impact of stopping rules on heterogeneity of results in overviews of clinical trials', Biometrics, 48, 41-53 (1992).
17. Berry, D. A. 'A case for Bayesianism in clinical trials', Statistics in Medicine, 12, 1377-1393 (1993).
18. Freedman, L. and Spiegelhalter, D. J. 'Application of Bayesian statistics to decision making during a clinical trial', Statistics in Medicine, 11, 23-35 (1992).
19. Honan, M. B., Harrell S. E., Jr, Reimer, K. A., Califf, R. M., Mark, D. B., Pryor, D. B. and Hlatky, M. A. 'Cardiac rupture, mortality, and the timing of thrombolytic therapy: a meta-analysis', Journal of the American College of Cardiology, 16, 359-367 (1990).
20. Trochim, W. M. and Cappelleri, J. C. 'Cutoff assignment strategies for enhancing randomized control trials', Controlled Clinical Trials, 13, 190-212 (1992).
21. Cappelleri, J. C. and Trochim, W. M. 'An illustrative statistical analysis of cutoff-based randomized clinical trials', Journal of Clinical Epidemiology, 47, 261-270 (1994).
22. Begg, C. 'The role of meta-analysis in monitoring clinical trials', Statistics in Medicine, 15, 1299-1306 (1996).